What is the role of HAS in early access programs in France?
HAS assesses and grants early access authorizations for innovative [...]
What is the Early Access Authorization (AAP) in France?
AAP is a French program allowing access to innovative medicines [...]
How do EAPs benefit pharmaceutical companies?
EAPs can provide real-world data, expose physicians to new drugs, [...]
What is the difference between the ATU and AAP programs in France?
The ATU (Temporary Authorization for Use) was the former French [...]
What is the Early Access Program (AAP) in France?
The Early Access Authorization (AAP) is a regulatory framework that [...]
